Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 1/2 1

Status

Completed 4Active not recruiting 3Not yet recruiting 2Withdrawn 1Terminated 1Recruiting 1

Sponsor Class

OTHER 2NIH 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Genitourinary 1CNS 1

Conditions

Urinary Bladder Neoplasms 1Postoperative Complications 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Liver Cirrhosis 1Leukemia 1Hodgkin Disease 1Hemorrhage 1Brain Neoplasms 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Furosemide × Clear all
NCT05741372 2026-01-13

A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis

Boehringer Ingelheim

Phase NA Completed
28 enrolled 15 charts

Liver Cirrhosis

NCT02356159 2025-09-30

Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
34 enrolled 18 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes

NCT02712476 2016-03-18

Brain Relaxation With Mannitol and Furosemide

Istanbul University

Phase NA Completed
47 enrolled
CNS

Brain Neoplasms

NCT02373735 2015-12-30

Effect of SVV Guided Fluid Therapy on Blood Loss and Postoperative Outcomes

Asan Medical Center

Phase NA Completed
64 enrolled
Genitourinary

Urinary Bladder Neoplasms, Hemorrhage, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡